InsiderClue
Insiders · Profile

Lian Brian

President & CEO at Viking Therapeutics. Filing since 30 Mar 2023. CIK 0001614578

Company
Date
Role
Action
Shares
Amount
Of holding
VKTX Viking Therapeutics, Inc.
29 Jul 2026
President & CEO
Sold at will
148,517
$4.95M
5.5%
VKTX Viking Therapeutics, Inc.
5 Jan 2026
President & CEO
Sold at will
233,409
$7.69M
8.5%
VKTX Viking Therapeutics, Inc.
28 Oct 2025
President & CEO
Sold at will
38,989
$1.36M
1.6%
VKTX Viking Therapeutics, Inc.
3 Jul 2025
President & CEO
Sold at will
26,889
$747.63K
1.1%
VKTX Viking Therapeutics, Inc.
6 Jan 2025
President & CEO
Sold at will
194,490
$8.31M
7.6%
VKTX Viking Therapeutics, Inc.
20 Sep 2024
President & CEO
Sold on a plan
216,130
$15.31M
8.6%
VKTX Viking Therapeutics, Inc.
21 Aug 2024
President & CEO
Sold on a plan
1,000
$69.90K
0.0%
VKTX Viking Therapeutics, Inc.
19 Aug 2024
President & CEO
Sold on a plan
112,870
$7.43M
4.6%
VKTX Viking Therapeutics, Inc.
30 Jul 2024
President & CEO
Sold at will
115,859
$6.67M
4.7%
VKTX Viking Therapeutics, Inc.
9 Feb 2024
President & CEO
Sold on a plan
45,000
$1.35M
2.1%
VKTX Viking Therapeutics, Inc.
8 Feb 2024
President & CEO
Sold on a plan
269,079
$7.23M
11.0%
VKTX Viking Therapeutics, Inc.
31 Jan 2024
President & CEO
Sold on a plan
85,000
$2.10M
3.6%
VKTX Viking Therapeutics, Inc.
30 Jan 2024
President & CEO
Sold on a plan
35,000
$838.25K
1.5%
VKTX Viking Therapeutics, Inc.
1 May 2023
President & CEO
Sold at will
45,000
$1.01M
2.0%
VKTX Viking Therapeutics, Inc.
19 Apr 2023
President & CEO
Sold at will
35,000
$750.75K
1.5%
VKTX Viking Therapeutics, Inc.
17 Apr 2023
President & CEO
Sold at will
155,000
$3.17M
6.4%
VKTX Viking Therapeutics, Inc.
13 Apr 2023
President & CEO
Sold at will
79,336
$1.46M
3.3%
VKTX Viking Therapeutics, Inc.
3 Apr 2023
President & CEO
Sold at will
22,000
$392.70K
1.0%
VKTX Viking Therapeutics, Inc.
31 Mar 2023
President & CEO
Sold at will
67,970
$1.19M
2.9%
VKTX Viking Therapeutics, Inc.
30 Mar 2023
President & CEO
Sold at will
153,382
$2.63M
6.4%
20 decisions on file.